Table: Kaken Pharmaceutical -2024/25 group forecast
Aug 7 (Reuters) -
Kaken Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2025 Mar 31, 2025
LATEST PREVIOUS
FORECAST FORECAST
Sales 88.50 75.10
Operating 20.80 7.40
Recurring 21.20 7.80
Net 14.20 5.60
EPS 374.97 yen 147.88 yen
NOTE - Kaken Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T